Navigation Links
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
Date:12/16/2008

NEWNAN, Ga., Dec. 16 /PRNewswire/ -- CeloNova BioSciences, Inc., announced today that it has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for Embozene(TM) Color-Advanced Microspheres which are indicated for the treatment of hypervascularized tumors (tumors with a large number of blood vessels in many locations) and arteriovenous malformations (defects in the circulatory system). U.S. commercial sales of Embozene(TM) Microspheres will begin immediately.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081216/CLTU022 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b )

Embozene(TM) Microspheres are the first and only microspheres to be color- enhanced with a different color for each size for increased procedural safety, efficiency and visibility. They are also available in a wider range of sizes than any other spherical embolic on the market. They are available in 40 micrometers, 100 micrometers, 250 micrometers, 400 micrometers, 500 micrometers, 700 micrometers, and 900 micrometers sizes in 1 ml and 2 ml pre-filled syringes and vials. CeloNova plans to submit a supplemental 510(k) to the FDA to add three additional sizes, 75 micrometers, 1100 micrometers and 1300 micrometers, for a total of ten sizes including the smallest and the largest microspheres available for endovascular therapy. CeloNova is the only Company that provides this complete range of products.

CeloNova's Embozene(TM) Microspheres consist of a hydrogel core and an exterior shell made from Polyzene(R)-F, CeloNova's proprietary polymer which is known to be anti-inflammatory and bacterial-resistant. Four design features distinguish Embozene(TM) Microspheres from other spherical embolics: biocompatibility, prec
'/>"/>

SOURCE CeloNova BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
2. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
3. Cell Biosciences Introduces First Protein Analysis Kits
4. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
5. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
6. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
7. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
8. Ardea Biosciences Announces Upcoming Corporate Meetings
9. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
10. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
11. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief (RTPR), makers ... rider David Mason has signed an official endorsement deal with the company. Originally from ... and his first bull at 15. He is an Australian bull riding champion, following ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Florida Companies to Watch for 2015 by economic development group GrowFL ... only 50 companies in the state selected for this prestigious award, which recognizes ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... by connecting accredited and institutional investors to real estate investment opportunities nationwide, today ... meet demand from both investors and sponsoring real estate companies. , ...
(Date:9/3/2015)... ... , ... Girl’s Night Out to benefit Core Compassion Project will be held ... in Monroe, North Carolina. The event food will be provided by Kate ... offers off-premise catering and event services from casual to elegant. They are also the ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... provider of comprehensive eating disorder treatment for adults and adolescents struggling with ... Calinoiu, MD has joined the medical treatment team. As a Staff Psychiatrist, ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... were to be reclassified again, according to campaigners. The UK’s ... the drug //is connected to mental disorders. This may result ... three years. It had been classified as a Class C ... to the use of the drug has to be conducted, ...
... had been opened by the Beth Israel Medical Center in ... which can be avoided // , are taking place in ... medical circles. The diabetes centers in the city conduct boot ... spite of this the Type 2 diabetes cases have increased ...
... its intentions of establishing its presence in Ontario and ... 2007. //The Health Minister of the Province has said ... if any legislation is contravened. It has been opined ... belittling the public health system, and more attention will ...
... the age of information and health and combining the two ... for the Ministry of Health (MOH) China has announced that ... AID/HIV epidemic soon. ,In his clarification and statement, "Last year, ... World Health Organization (WHO) jointly estimated China's AIDS epidemic, and ...
... be on the decline. The current winter figures are only at between ... been on the decline since 2001. The threat from the avian flu ... immunity that the people in the country have gained to the H3N2 ... ,Most of the infected in the current winter are among ...
... revealed that two more people in China have succumbed to the ... // . The latest victims were a 35-year-old man and ... both the deaths. ,This does not mean that ... China, but it's a reminder that it is a very serious ...
Cached Medicine News:Health News:US Continues Its War On Diabetes 2Health News:Copeman Healthcare To Establish Private Clinics 2
(Date:9/3/2015)... , Sept. 3, 2015 ... a condition that involves narrowing or blockage of ... heart rhythm problems, smoking, high cholesterol, and high ... arterial disease, atherosclerosis, and heart failure are some ... obstruction of blood vessels, especially coronary arteries, is ...
(Date:9/3/2015)... , Sept. 3, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... presenting at the Morgan Stanley Global Healthcare Conference on ... Nevro management is scheduled to present at ... a live audio webcast, accessible in the "Investors" section ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
Breaking Medicine Technology:Global Cardiovascular Implants Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... February 27 Novagali Pharma, a French,pharmaceutical ... first set of,data pertaining to Nova21027, its ... Novagali communicated about "Ocular ... conventional formulations of prostaglandin,analogues: an in vivo ...
... /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: ... of its new drug application ("NDA") for AFRESA(R), an ultra ... As previously announced, our internal goal was to submit the ... end of February. Based on editorial decisions made during ...
Cached Medicine Technology:Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma 2MannKind Updates Status of NDA Submission for AFRESA 2MannKind Updates Status of NDA Submission for AFRESA 3
A simple testing set for prescribing aspheric spectacle magnifiers. Redi-glaze lenses are available for instant dispensing which are cut and edged to fit our standard LVA frame....
... to 20 tilting tower ... the vertical, horizontal and ... option to offset the ... ,Filters include Cobalt blue; ...
... the outstanding optical system of the Keeler ... external fibre optic illumination system with diffuser ... digital camera. The result is an excellent ... the option of capturing stills or video ...
Assists in early recognition of changes in the macula and foveal areas., ,Only 6 patient responses required for diagnosis of functional disturbances, from small scotoma to distortions. Full instructi...
Medicine Products: